Charles River Laboratories International (CRL) Non-Current Deferred Tax Liability (2010 - 2026)

Charles River Laboratories International has reported Non-Current Deferred Tax Liability for 15 years, with the latest figure at $78.7 million in Q2 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 28.01% year-over-year to $78.7 million in Q2 2026; TTM through Jun 2026 was $78.7 million, a 28.01% decrease from a year earlier, with the FY2025 full-year figure at $95.2 million, down 75.11% from the prior year.
• Non-Current Deferred Tax Liability was $78.7 million for Q2 2026 at Charles River Laboratories International, down from $81.4 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $441.4 million in Q4 2023, with the low at $78.7 million in Q2 2026.
• Average Non-Current Deferred Tax Liability over 5 years is $201.5 million, with a median of $182.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Non-Current Deferred Tax Liability advanced 11.56% in 2022, then sank 75.11% in 2025.
• Over 5 years, Non-Current Deferred Tax Liability stood at $433.1 million in 2022, then increased by 1.92% to $441.4 million in 2023, then retreated by 13.35% to $382.5 million in 2024, then tumbled by 75.11% to $95.2 million in 2025, then decreased by 17.37% to $78.7 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $78.7 million (Q2 2026), $81.4 million (Q1 2026), and $95.2 million (Q4 2025), per Business Quant data.